Glenmede Trust CO Na Axsome Therapeutics, Inc. Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

A detailed history of Glenmede Trust CO Na transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 7,473 shares of AXSM stock, worth $727,646. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,473

Previous 7,403 0.95%

Holding current value

$727,646

Previous $595,000 12.77%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$78.93 - $95.84 $5,525 - $6,708	70 Added 0.95%	7,473 $671,000
Q2 2024 Aug 14, 2024	BUY	$65.72 - $80.5 $6,637 - $8,130	101 Added 1.38%	7,403 $595,000
Q1 2024 May 15, 2024	SELL	$69.39 - $97.64 $4,371 - $6,151	-63 Reduced 0.86%	7,302 $582,000
Q4 2023 Feb 13, 2024	SELL	$57.42 - $83.61 $48,117 - $70,065	-838 Reduced 10.22%	7,365 $586,000
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $279,146 - $331,388	4,031 Added 96.62%	8,203 $573,000
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $139,552 - $179,250	-2,390 Reduced 36.42%	4,172 $257,000
Q4 2022 Feb 14, 2023	SELL	$39.94 - $79.72 $359,420 - $717,400	-8,999 Reduced 57.83%	6,562 $506,000
Q3 2022 Nov 16, 2022	BUY	$36.06 - $69.85 $356,128 - $689,838	9,876 Added 173.72%	15,561 $694,000
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $123,591 - $265,773	5,685 New	5,685 $217,000
Q1 2022 May 16, 2022	SELL	$23.7 - $41.39 $131,179 - $229,093	-5,535 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$30.7 - $43.36 $169,924 - $239,997	5,535 New	5,535 $209,000
Q3 2021 Nov 15, 2021	SELL	$19.91 - $68.26 $109,505 - $375,430	-5,500 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$50.63 - $73.5 $11,898 - $17,272	-235 Reduced 4.1%	5,500 $371,000
Q1 2021 May 18, 2021	BUY	$55.91 - $81.44 $3,354 - $4,886	60 Added 1.06%	5,735 $324,000
Q4 2020 Feb 16, 2021	BUY	$66.31 - $86.52 $37,266 - $48,624	562 Added 10.99%	5,675 $462,000
Q3 2020 Nov 16, 2020	BUY	$68.34 - $85.84 $169,483 - $212,883	2,480 Added 94.19%	5,113 $364,000
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $123,328 - $244,060	-2,473 Reduced 48.43%	2,633 $216,000
Q4 2019 Feb 12, 2020	SELL	$16.71 - $106.24 $15,022 - $95,509	-899 Reduced 14.97%	5,106 $527,000
Q3 2019 Nov 14, 2019	BUY	$20.24 - $29.16 $51,510 - $74,212	2,545 Added 73.55%	6,005 $121,000
Q2 2019 Aug 13, 2019	BUY	$13.46 - $25.75 $46,571 - $89,095	3,460 New	3,460 $89,000

Others Institutions Holding AXSM

# of Institutions

324

Shares Held

37.7M

Call Options Held

797K

Put Options Held

747K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.18B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Axsome Therapeutics, Inc. Transaction History